BIOPHARMA
By
Could GSK’s Twice-Yearly Asthma Drug Change Long-Term Treatment for Patients?
United States GlaxoSmithKline (GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved its new…
Inductive Bio and Amgen Collaborate With ARPA-H to Advance AI-Based Alternatives to Animal Toxicology Testing
United States Inductive Bio, a New York–based artificial intelligence company focused on drug discovery, has been awarded up…
Amgen Takes Steps With U.S. Government to Reduce Prescription Drug Costs for American Patients
Thousand Oaks, California Amgen announced that it is working with the U.S. government on new measures aimed at…
Could CagriSema Become the First Once-Weekly GLP-1 and Amylin Combination Approved by the FDA?
United States / Denmark Novo Nordisk has submitted a New Drug Application to the U.S. Food and Drug…
Is Pfizer Facing New Safety Scrutiny After Reporting a Patient Death in Its Hympavzi Hemophilia Trial?
Pfizer has disclosed that a patient enrolled in a clinical trial evaluating its investigational hemophilia treatment Hympavzi died…
How Is Pfizer Expanding Its Oncology Pipeline Through T-Cell–Targeted Immunotherapy for Prostate Cancer?
Cambridge, Massachusetts Pfizer is strengthening its oncology research pipeline through a new program launched under its strategic collaboration…
